Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Chaganti, RSK' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 141 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hatzivassiliou, G; Miller, I; Takizawa, J; Palanisamy, N; Rao, PH; Iida, S; Tagawa, S; Taniwaki, M; Russo, J; Neri, A; Cattoretti, G; Clynes, R; Mendelsohn, C; Chaganti, RSK; Dalla-Favera, R
      IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in Bcells and involved in chromosome 1q21 abnormalities in B cell malignancy

      IMMUNITY
    2. Albanese, JM; Reuter, VE; Bosl, GJ; Houldsworth, J; Chaganti, RSK
      Expression of ID genes in differentiated elements of human male germ cell tumors

      DIAGNOSTIC MOLECULAR PATHOLOGY
    3. Chen, WY; Itoyama, T; Chaganti, RSK
      Splicing factor SRP20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma

      GENES CHROMOSOMES & CANCER
    4. Chen, WY; Palanisamy, N; Schmidt, H; Teruya-Feldstein, J; Jhanwar, SC; Zelenetz, AD; Houldsworth, J; Chaganti, RSK
      Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas

      ONCOGENE
    5. Houldsworth, J; Reuter, VE; Bosl, GJ; Chaganti, RSK
      ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines

      CELL AND TISSUE RESEARCH
    6. Odero, MD; Soto, JL; Matutes, E; Martin-Subero, JI; Zudaire, I; Rao, PH; Cigudosa, JC; Ardanaz, MT; Chaganti, RSK; Perucho, M; Calasanz, MJ
      Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL

      CANCER GENETICS AND CYTOGENETICS
    7. Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R
      Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

      NATURE
    8. Itoyama, A; Chaganti, RSK; Yamada, Y; Tsukasaki, K; Atogami, S; Nakamura, H; Tomonaga, M; Ohshima, K; Kikuchi, M; Sadamori, N
      Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki

      BLOOD
    9. Hauptschein, RS; Gaidano, G; Rao, PH; Scotto, L; Edwards, YH; Chaganti, RSK; Dalla-Favera, R
      An apparent interlocus gene conversion-like event at a putative tumor suppressor gene locus on human chromosome 6q27 in a Burkitt's lymphoma cell line

      DNA RESEARCH
    10. Huang, Q; Schantz, SP; Rao, PH; Mo, J; McCormick, SA; Chaganti, RSK
      Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors

      GENES CHROMOSOMES & CANCER
    11. Bala, S; Oliver, H; Renault, B; Montgomery, K; Dutta, S; Rao, P; Houldsworth, L; Kucherlapati, R; Wang, XD; Chaganti, RSK; Murty, VVVS
      Genetic analysis of the APAFI gene in male germ cell tumors

      GENES CHROMOSOMES & CANCER
    12. Schantz, SP; Huang, Q; Shah, K; Murty, VVVS; Hsu, TC; Yu, GP; Andersen, PE; Huvos, AG; Chaganti, RSK
      Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers

      CARCINOGENESIS
    13. Chaganti, RSK; Nanjangud, G; Schmidt, H; Teruya-Feldstein, J
      Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: Biologic and clinical significance

      SEMINARS IN HEMATOLOGY
    14. Brown, SB; Brierley, TT; Palanisamy, N; Salusky, IB; Goodman, W; Brandi, ML; Drueke, TB; Sarfati, E; Urena, P; Chaganti, RSK; Pike, JW; Arnold, A
      Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    15. Chaganti, RSK; Houldsworth, J
      Genetics and biology of adult human male germ cell tumors

      CANCER RESEARCH
    16. Dyomin, VG; Palanisamy, N; Lloyd, KO; Dyomina, K; Jhanwar, SC; Houldsworth, J; Chaganti, RSK
      MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets

      BLOOD
    17. Murty, VVVS; Montgomery, K; Dutta, S; Bala, S; Renault, B; Bosl, GJ; Kucherlapati, R; Chaganti, RSK
      A 3-Mb high-resolution BAC/PAC contig of 12q22 encompassing the 830-kb consensus minimal deletion in male germ cell tumors

      GENOME RESEARCH
    18. Cigudosa, JC; Parsa, NZ; Louie, DC; Filippa, DA; Jhanwar, SC; Johansson, B; Mitelman, F; Chaganti, RSK
      Cytogenetic analysis of 363 consecutively ascertained diffuse large B-celllymphomas

      GENES CHROMOSOMES & CANCER
    19. Butler, MP; Wang, SI; Chaganti, RSK; Parsons, R; Dalla-Favera, R
      Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas

      GENES CHROMOSOMES & CANCER
    20. Stoffel, A; Rao, PH; Louie, DC; Krauter, K; Liebowitz, DN; Koeppen, H; Le Beau, MM; Chaganti, RSK
      Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC

      GENES CHROMOSOMES & CANCER
    21. Iida, S; Rao, PH; Ueda, R; Chaganti, RSK; Dalla-Favera, R
      Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphomawith t(9;14)(p13;q32)

      LEUKEMIA & LYMPHOMA
    22. Edelmann, L; Pandita, RK; Spiteri, E; Funke, B; Goldberg, R; Palanisamy, N; Chaganti, RSK; Magenis, E; Shprintzen, RJ; Morrow, BE
      A common molecular basis for rearrangement disorders on chromosome 22q11

      HUMAN MOLECULAR GENETICS
    23. Fakruddin, JM; Chaganti, RSK; Murty, VVVS
      Lack of BCL10 mutations in germ cell tumors and B cell lymphomas

      CELL
    24. CHAGANTI SR; CHEN WY; PARSA N; OFFIT K; LOUIE DC; DALLAFAVERA R; CHAGANTI RSK
      INVOLVEMENT OF BCL6 IN CHROMOSOMAL-ABERRATIONS AFFECTING BAND 3Q27 INB-CELL NON-HODGKIN-LYMPHOMA

      Genes chromosomes & cancer (Print)
    25. CHAGANTI SR; RAO PH; CHEN WY; DYOMIN V; JHANWAR SC; PARSA NZ; DALLAFAVERA R; CHAGANTI RSK
      DEREGULATION OF BCL6 IN NON-HODGKIN-LYMPHOMA BY INSERTION OF IGH SEQUENCES IN COMPLEX TRANSLOCATIONS INVOLVING BAND 3Q27

      Genes chromosomes & cancer (Print)
    26. LYDIATT WM; DAVIDSON BJ; SCHANTZ SP; CARUANA S; CHAGANTI RSK
      9P21 DELETION CORRELATES WITH RECURRENCE IN HEAD AND NECK-CANCER

      Head & neck
    27. Qu, XY; Hauptschein, RS; Rzhetsky, A; Scotto, L; Chien, MC; Ye, XL; Frigeri, F; Rao, PH; Pasqualucci, L; Gamberi, B; Deaven, LL; Zhang, PS; Chaganti, RSK; Dalla-Favera, R; Russo, JJ
      Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27

      DNA SEQUENCE
    28. CHEN WY; BUTLER M; RAO PH; CHAGANTI SR; LOUIE DC; DALLAFAVERA R; CHAGANTI RSK
      THE T(2-3)(Q21-Q27) TRANSLOCATION IN NON-HODGKINS-LYMPHOMA DISPLAYS BCL6 MUTATIONS IN THE 5' REGULATORY REGION AND CHROMOSOMAL BREAKPOINTS DISTANT FROM THE GENE

      Oncogene
    29. HOULDSWORTH J; XIAO H; MURTY VVVS; CHEN WY; RAY B; REUTER VE; BOSL GJ; CHAGANTI RSK
      HUMAN MALE GERM-CELL TUMOR RESISTANCE TO CISPLATIN IS LINKED TO TP53 GENE MUTATION

      Oncogene
    30. CHAGANTI RSK; HOULDSWORTH J
      THE CYTOGENETIC THEORY OF THE PATHOGENESIS OF HUMAN ADULT MALE GERM-CELL TUMORS - REVIEW ARTICLE

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    31. HAUPTSCHEIN RS; GAMBERI B; RAO PH; FRIGERI F; SCOTTO L; VENKATRAJ VS; GAIDANO G; RUTNER T; EDWARDS YH; CHAGANTI RSK; DALLAFAVERA R
      CLONING AND MAPPING OF HUMAN-CHROMOSOME 6Q26-Q27 DELETED IN B-CELL NON-HODGKIN-LYMPHOMA AND MULTIPLE TUMOR TYPES

      Genomics
    32. RAO PH; MURTY VVVS; LOUIE DC; CHAGANTI RSK
      NONSYSTEMIC AMPLIFICATION OF MYC WITH CDK4 AND MDM2 IN A MALIGNANT MIXED TUMOR OF SALIVARY-GLAND

      Cancer genetics and cytogenetics
    33. MURTY VVVS; CHAGANTI RSK
      A GENETIC PERSPECTIVE OF MALE GERM-CELL TUMORS

      Seminars in oncology
    34. PASQUALUCCI L; MIGLIAZZA A; FRACCHIOLLA N; WILLIAM C; NERI A; BALDINI L; CHAGANTI RSK; KLEIN U; KUPPERS R; RAJEWSKY K; DALLAFAVERA R
      BCL-6 MUTATIONS IN NORMAL GERMINAL CENTER B-CELLS - EVIDENCE OF SOMATIC HYPERMUTATION ACTING OUTSIDE IG LOCI

      Proceedings of the National Academy of Sciences of the United Statesof America
    35. MOTZER RJ; AMSTERDAM A; PRIETO V; SHEINFELD J; MURTY VVS; MAZUMDAR M; BOSL GJ; CHAGANTI RSK; REUTER VE
      TERATOMA WITH MALIGNANT TRANSFORMATION - DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM-CELL TUMORS

      The Journal of urology
    36. PALANISAMY N; IMANISHI Y; RAO PH; TAHARA H; CHAGANTI RSK; ARNOLD A
      NOVEL CHROMOSOMAL-ABNORMALITIES IDENTIFIED BY COMPARATIVE GENOMIC HYBRIDIZATION IN PARATHYROID ADENOMAS

      The Journal of clinical endocrinology and metabolism
    37. LIN RY; VERA JC; CHAGANTI RSK; GOLDE DW
      HUMAN MONOCARBOXYLATE TRANSPORTER 2 (MCT2) IS A HIGH-AFFINITY PYRUVATE TRANSPORTER

      The Journal of biological chemistry
    38. RAO PH; HOULDSWORTH J; PALANISAMY N; MURTY VVVS; REUTER VE; MOTZER RJ; BOSL GJ; CHAGANTI RSK
      CHROMOSOMAL AMPLIFICATION IS ASSOCIATED WITH CISPLATIN RESISTANCE OF HUMAN MALE GERM-CELL TUMORS

      Cancer research
    39. CHAGANTI RSK
      DETECTION OF NONRANDOM CHROMOSOMAL CHANGES IN MULTIPLE-MYELOMA BY COMPARATIVE GENOMIC HYBRIDIZATION - RESPONSE

      Blood
    40. RAO PH; CIGUDOSA JC; NING Y; CALASANZ MJ; IIDA S; TAGAWA S; MICHAELI J; KLEIN B; DALLAFAVERA R; JHANWAR SC; RIED T; CHAGANTI RSK
      MULTICOLOR SPECTRAL KARYOTYPING IDENTIFIES NEW RECURRING BREAKPOINTS AND TRANSLOCATIONS IN MULTIPLE-MYELOMA

      Blood
    41. RAO PH; HOULDSWORTH J; DYOMINA K; PARSA NZ; CIGUDOSA JC; LOUIE DC; POPPLEWELL L; OFFIT K; JHANWAR SC; CHAGANTI RSK
      CHROMOSOMAL AND GENE AMPLIFICATION IN DIFFUSE LARGE B-CELL LYMPHOMA

      Blood
    42. CIGUDOSA JC; RAO PH; CALASANZ MJ; ODERO MD; MICHAELI J; JHANWAR SC; CHAGANTI RSK
      CHARACTERIZATION OF NONRANDOM CHROMOSOMAL GAINS AND LOSSES IN MULTIPLE-MYELOMA BY COMPARATIVE GENOMIC HYBRIDIZATION

      Blood
    43. CHEN WY; IIDA S; LOUIE DC; DALLAFAVERA R; CHAGANTI RSK
      HETEROLOGOUS PROMOTERS FUSED TO BCL6 BY CHROMOSOMAL TRANSLOCATIONS AFFECTING BAND 3Q27 CAUSE ITS DEREGULATED EXPRESSION DURING B-CELL DIFFERENTIATION

      Blood
    44. IIDA S; RAO PH; BUTLER M; CORRADINI P; BOCCADORO M; KLEIN B; CHAGANTI RSK; DALLAFAVERA R
      DEREGULATION OF MUM1 IRF4 BY CHROMOSOMAL TRANSLOCATION IN MULTIPLE-MYELOMA/

      Nature genetics
    45. YE BH; CATTORETTI G; SHEN QO; ZHANG JD; HAWE N; DEWAARD R; LEUNG C; NOURISHIRAZI M; ORAZI A; CHAGANTI RSK; ROTHMAN P; STALL AM; PANDOLFI PP; DALLAFAVERA R
      THE BCL-6 PROTOONCOGENE CONTROLS GERMINAL-CENTER FORMATION AND TH2-TYPE INFLAMMATION

      Nature genetics
    46. HOULDSWORTH J; REUTER V; BOSL GJ; CHAGANTI RSK
      ABERRANT EXPRESSION OF CYCLIN D2 IS AN EARLY EVENT IN HUMAN MALE GERM-CELL TUMORIGENESIS

      Cell growth & differentiation
    47. PALANISAMY N; CHAGANTI RSK; ARNOLD A
      NOVEL CHROMOSOMAL-ABNORMALITIES IN PARATHYROID ADENOMAS IDENTIFIED BYCOMPARATIVE GENOMIC HYBRIDIZATION (CGH)

      Journal of bone and mineral research
    48. DYOMIN VG; RAO PH; DALLAFAVERA R; CHAGANTI RSK
      BCL8, A NOVEL GENE INVOLVED IN TRANSLOCATIONS AFFECTING BAND 15Q11-13IN DIFFUSE LARGE-CELL LYMPHOMA

      Proceedings of the National Academy of Sciences of the United Statesof America
    49. PALANISAMY N; RAO PH; ABOUELELLA A; WEISENBURGER DD; CHAGANTI RSK
      COMPARISON OF PRIMARY MEDIASTINAL LARGE B-CELL AND DIFFUSE LARGE-CELLLYMPHOMAS - GENETIC ANOMALIES DEFINED BY CGH

      Blood
    50. RAO PH; CIGUDOSA J; NING Y; CALASANZ MJ; TAGAWA S; MICHAELE S; KLEIN B; DALLAFAVERA R; RIED T; CHAGANTI RSK
      KARYOTYPIC COMPLEXITY OF MULTIPLE-MYELOMA DEFINED BY MULTICOLOR SPECTRAL KARYOTYPING (SKY)

      Blood
    51. CATTORETTI G; ZHANG J; CLEARY AM; LEDERMAN S; GAIDANO G; CARBONE A; CHAGANTI RSK; DALLAFAVERA R
      DOWN-REGULATION OF BCL-6 GENE-EXPRESSION BY CD40 AND EBV LATENT MEMBRANE PROTEIN-1 (LMP-1) AND ITS BLOCK IN LYMPHOMA CARRYING BCL-6 REARRANGEMENTS

      Blood
    52. KRUEGER LJ; RAO PH; DALLAFAVERA R; LIN JC; DUNN SP; CHAGANTI RSK
      3RD-ARM IN B-CELL LYMPHOMAGENESIS - FREQUENT GENOMIC IMBALANCES AND AMPLIFICATION OF BCL6 IN BURKITTS-LYMPHOMA

      Blood
    53. MIGLIAZZA A; YE BH; FRACCHIOLLA N; NERI A; BALDINI L; CHAGANTI RSK; DALLAFAVERA R
      MUTATIONS OF THE 5'-NONCODING REGION OF BCL-6 ARE COMMON IN B-CELL MALIGNANCIES AND CAN DEREGULATE BCL-6 EXPRESSION

      Blood
    54. BUTLER M; IIDA S; RAO P; LOUIE D; HOULDSWORTH J; CHAGANTI S; CHAGANTI RSK; DALLAFAVERA R
      IDENTIFICATION OF AN ALTERNATIVE CHROMOSOMAL BREAKPOINT SITE 5' TO THE BCL-6 LOCUS IN DIFFUSE LARGE-CELL LYMPHOMA

      Blood
    55. NIU H; YE BH; CHAGANTI RSK; DALLAFAVERA R
      ANTIGEN RECEPTOR-INDUCED, MAP KINASE-MEDIATED SIGNALING PATHWAY LEADING TO BCL-6 PHOSPHORYLATION AND DEGRADATION IN B-CELLS

      Blood
    56. GAMBERI B; GAIDANO G; PARSA N; CARBONE A; RONCELLA S; KNOWLES DM; LOUIE DC; SHIBATA D; CHAGANTI RSK; DALLAFAVERA R
      MICROSATELLITE INSTABILITY IS RARE IN B-CELL NON-HODGKINS-LYMPHOMAS

      Blood
    57. MURTY VVVS; RENAULT B; KUCHERLAPATI R; CHAGANTI RSK
      GENERATION OF A PHYSICAL MAP OF GREATER-THAN-2MB REGION AT 12Q22 DELETED IN MALE GERM-CELL TUMORS TOWARD THE IDENTIFICATION OF CANDIDATE DGCT1 GENE

      American journal of human genetics
    58. SELVAKUMAR A; STEFFENS U; PALANISAMY N; CHAGANTI RSK; DUPONT B
      GENOMIC ORGANIZATION AND ALLELIC POLYMORPHISM OF THE HUMAN KILLER-CELL INHIBITORY RECEPTOR GENE KIR103

      Tissue antigens
    59. BORROW J; STANTON VP; ANDRESEN JM; BECHER R; BEHM FG; CHAGANTI RSK; CIVIN CI; DISTECHE C; DUBE I; FRISCHAUF AM; HORSMAN D; MITELMAN F; VOLINIA S; WATMORE AE; HOUSMAN DE
      THE TRANSLOCATION T(8-L6)(P11, P13) OF ACUTE MYELOID-LEUKEMIA FUSES APUTATIVE ACETYLTRANSFERASE TO THE CREB BINDING-PROTEIN

      Nature genetics
    60. DAVIDSON BJ; LYDIATT WM; ABATE MP; SCHANTZ SP; CHAGANTI RSK
      CYCLIN D1 ABNORMALITIES AND TOBACCO EXPOSURE IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Head & neck
    61. MURTY VVVS; REUTER VE; BOSL GJ; CHAGANTI RSK
      DELETION MAPPING IDENTIFIES LOSS OF HETEROZYGOSITY AT 5P15.1-15.2, 5Q11 AND 5Q34-35 IN HUMAN MALE GERM-CELL TUMORS

      Oncogene
    62. MURTY VVVS; RENAULT B; FALK CT; BOSL GJ; KUCHERLAPATI R; CHAGANTI RSK
      PHYSICAL MAPPING OF A COMMONLY DELETED REGION, THE SITE OF A CANDIDATE TUMOR-SUPPRESSOR GENE, AT 12Q22 IN HUMAN MALE GERM-CELL TUMORS

      Genomics
    63. PARIKH PM; DESAI S; NARESH KN; SHAKUNTAKA B; LAXMINARAYAN K; NAIR CN; LADANYI M; SOMAN CS; ADVANI SH; CHAGANTI RSK
      INCIDENCE OF 5'-BCL-2 REARRANGEMENT IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA FROM INDIA

      Leukemia research
    64. CHANG CC; YE BH; CHAGANTI RSK; DALLAFAVERA R
      BCL-6, A POZ ZINC-FINGER PROTEIN, IS A SEQUENCE-SPECIFIC TRANSCRIPTIONAL REPRESSOR/

      Proceedings of the National Academy of Sciences of the United Statesof America
    65. LIDA S; RAO PH; NALLASIVAM P; HIBSHOOSH H; BUTLER M; LOUIE DC; DYOMIN V; OHNO H; CHAGANTI RSK; DALLAFAVERA R
      THE T(9-14)(P13-Q32) CHROMOSOMAL TRANSLOCATION ASSOCIATED WITH LYMPHOPLASMOCYTOID LYMPHOMA INVOLVES THE PAX-5 GENE

      Blood
    66. LOUIE DC; TRAINA TA; PARSA N; LINKOV I; CHAGANTI RSK
      IMMUNOHISTOCHEMICAL DETECTION OF CYCLIN D1 OVEREXPRESSION IN MULTIPLE-MYELOMA AND PLASMACYTOID LYMPHOMAS WITH T(11-14)(Q13-Q32)

      Blood
    67. CATTORETTI G; YE BH; HAWE N; NOURISHIRAZI M; STALL A; CHAGANTI RSK; PANDOLFI PP; DALLAFAVERA R
      BCL-6 IS INVOLVED IN GERMINAL CENTER FORMATION

      Blood
    68. IIDA S; BUTLER M; RAO P; CORRADINI P; BOCCADORO M; KLEIN B; CHAGANTI RSK; DALLAFAVERA R
      MUM1 1CSAT, A MEMBER OF THE INTERFERON REGULATORY FACTOR FAMILY (IRF), IS INVOLVED IN CHROMOSOMAL TRANSLOCATIONS IN MULTIPLE-MYELOMA/

      Blood
    69. DYOMIN VG; RAO PH; DALLAFAVERA R; CHAGANTI RSK
      CLONING OF THE BCL8 GENE INVOLVED IN CHROMOSOMAL TRANSLOCATIONS AFFECTING BAND 15Q11-13 IN DIFFUSE LARGE-CELL LYMPHOMAS

      Blood
    70. HOULDSWORTH J; MATHEW S; RAO PH; DYOMINA K; LOUIE DC; PARSA N; OFFIT K; CHAGANTI RSK
      REL PROTOONCOGENE IS FREQUENTLY AMPLIFIED IN EXTRANODAL DIFFUSE LARGE-CELL LYMPHOMA

      Blood
    71. LYDIATT WM; MURTY VVVS; DAVIDSON BJ; XU L; DYOMINA K; SACKS PG; SCHANTZ SP; CHAGANTI RSK
      HOMOZYGOUS DELETIONS AND LOSS OF EXPRESSION OF THE CDKN2 GENE OCCUR FREQUENTLY IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA CELL-LINES BUT INFREQUENTLY IN PRIMARY TUMORS

      Genes, chromosomes & cancer
    72. CHAGANTI SR; GAIDANO G; LOUIE DC; DALLAFAVERA R; CHAGANTI RSK
      DIFFUSE LARGE-CELL LYMPHOMAS EXHIBIT FREQUENT DELETIONS IN 9P21-22 AND 9Q31-34 REGIONS

      Genes, chromosomes & cancer
    73. OFFIT K; LOUIE DC; PARSA NZ; ROY P; LEUNG D; LOCOCO F; ZELENETZ A; DALLAFAVERA R; CHAGANTI RSK
      BCL6 GENE REARRANGEMENT AND OTHER CYTOGENETIC ABNORMALITIES IN DIFFUSE LARGE-CELL LYMPHOMA

      Leukemia & lymphoma
    74. MATHEW S; CHEN WY; MURTY VVVS; BENEZRA R; CHAGANTI RSK
      CHROMOSOMAL ASSIGNMENT OF HUMAN ID1 AND ID2 GENES

      Genomics
    75. MATHEW S; SCANLAN MJ; RAJ BKM; MURTY VVVS; GARINCHESA P; OLD LJ; RETTIG WJ; CHAGANTI RSK
      THE GENE FOR FIBROBLAST ACTIVATION PROTEIN-ALPHA (FAP), A PUTATIVE CELL SURFACE-BOUND SERINE-PROTEASE EXPRESSED IN CANCER STROMA AND WOUND-HEALING, MAPS TO CHROMOSOME BAND 2Q23

      Genomics
    76. MOTZER RJ; RODRIGUEZ E; REUTER VE; BOSL GJ; MAZUMDAR M; CHAGANTI RSK
      MOLECULAR AND CYTOGENETIC STUDIES IN THE DIAGNOSIS OF PATIENTS WITH POORLY DIFFERENTIATED CARCINOMAS OF UNKNOWN PRIMARY SITE

      Journal of clinical oncology
    77. YE BH; MIGLIAZZA A; MARTINOTTI S; FUSCO C; CHAGANTI SR; CHEN W; CHANG CC; OFFIT K; CHAGANTI RSK; DALLAFAVERA R
      ALTERATIONS OF A ZINC-FINGER GENE, BCL-6, IN B-CELL LYMPHOMA

      Journal of cellular biochemistry
    78. YE BH; CHAGANTI S; CHANG CC; NIU H; CORRADINI P; CHAGANTI RSK; DALLAFAVERA R
      CHROMOSOMAL TRANSLOCATIONS CAUSE DEREGULATED BCL6 EXPRESSION BY PROMOTER SUBSTITUTION IN B-CELL LYMPHOMA

      EMBO journal
    79. RODRIGUEZ E; MELAMED J; REUTER V; CHAGANTI RSK
      CHROMOSOME-12 ABNORMALITIES IN MALIGNANT OVARIAN GERM-CELL TUMORS

      Cancer genetics and cytogenetics
    80. RAO PH; MATHEW S; KELSEN DP; CHAGANTI RSK
      CYTOGENETICS OF GASTRIC AND ESOPHAGEAL ADENOCARCINOMAS - 3Q DELETION AS A POSSIBLE PRIMARY CHROMOSOMAL CHANGE

      Cancer genetics and cytogenetics
    81. RODRIGUEZ E; MELAMED J; REUTER V; CHAGANTI RSK
      CHROMOSOMAL-ABNORMALITIES IN CHORIOCARCINOMAS OF THE FEMALE

      Cancer genetics and cytogenetics
    82. DUTTLINGER R; MANOVA K; BERROZPE G; CHU TY; DELEON V; TIMOKHINA I; CHAGANTI RSK; ZELENETZ AD; BACHVAROVA RF; BESMER P
      THE W-SH AND PH MUTATIONS AFFECT THE C-KIT EXPRESSION PROFILE - C-KITMISEXPRESSION IN EMBRYOGENESIS IMPAIRS MELANOGENESIS IN W-SH AND PH MUTANT MICE

      Proceedings of the National Academy of Sciences of the United Statesof America
    83. MIGLIAZZA A; MARTINOTTI S; CHEN WY; FUSCO C; YE BH; KNOWLES DM; OFFIT K; CHAGANTI RSK; DALLAFAVERA R
      FREQUENT SOMATIC HYPERMUTATION OF THE 5'-NONCODING REGION OF THE BCL6GENE IN B-CELL LYMPHOMA

      Proceedings of the National Academy of Sciences of the United Statesof America
    84. CHAGANTI RSK; BOSL GJ
      GERM-CELL TUMORS - UNRAVELING A BIOLOGICAL PARADOX

      Laboratory investigation
    85. LOUIE DC; OFFIT K; JASLOW R; PARSA NZ; MURTY VVVS; SCHLUGER A; CHAGANTI RSK
      P53 OVEREXPRESSION AS A MARKER OF POOR-PROGNOSIS IN MANTLE CELL LYMPHOMAS WITH T(11-14)(Q13-Q32)

      Blood
    86. OFFIT K; LOUIE DC; PARSA NZ; NOY A; CHAGANTI RSK
      DEL(7)(Q32) IS ASSOCIATED WITH A SUBSET OF SMALL LYMPHOCYTIC LYMPHOMAWITH PLASMACYTOID FEATURES

      Blood
    87. LOUIE D; HOULDSWORTH J; OFFIT K; MATHEW S; DYOMINA K; RAO PH; PARSA N; CHAGANTI RSK
      REL AMPLIFICATION IS FREQUENT IN DIFFUSE LARGE-CELL LYMPHOMA (DLLC)

      Blood
    88. IIDA S; RAO P; BUTLER M; OHNO H; OFFIT K; CHAGANTI RSK; DALLAFAVERA R
      CHROMOSOMAL TRANSLOCATION (9-14)(P13-Q32), ASSOCIATED WITH SMALL LYMPHOCYTIC LYMPHOMA, INVOLVES THE PAX-5 GENE

      Blood
    89. GAMBERI B; GAIDANO G; PARSA NZ; LOUIE DC; RONCELLA S; FERRARINI M; SHIBATA D; KNOWLES DM; CHAGANTI RSK; DALLAFAVERA R
      ABSENCE OF MICROSATELLITE INSTABILITY IN NON-HODGKIN LYMPHOMAS

      Blood
    90. CATTORETTI G; CHANG CC; CECHOVA K; ZHANG JD; YE BH; FALINI B; LOUIE DC; OFFIT K; CHAGANTI RSK; DALLAFAVERA R
      BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS

      Blood
    91. MITRA AB; MURTY VVVS; SINGH V; LI RG; PRATAP M; SODHANI P; LUTHRA UK; CHAGANTI RSK
      GENETIC ALTERATIONS AT 5P15 - A POTENTIAL MARKER FOR PROGRESSION OF PRECANCEROUS LESIONS OF THE UTERINE CERVIX

      Journal of the National Cancer Institute
    92. PARSA NZ; GAIDANO G; MUKHERJEE AB; HAUPTSCHEIN RS; LENOIR G; DALLAFAVERA R; CHAGANTI RSK
      CYTOGENETIC AND MOLECULAR ANALYSIS OF 6Q-DELETIONS IN BURKITTS-LYMPHOMA CELL-LINES

      Genes, chromosomes & cancer
    93. SREEKANTAIAH C; RAO PH; XU L; SACKS PG; SCHANTZ SP; CHAGANTI RSK
      CONSISTENT CHROMOSOMAL BOSSES IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA CELL-LINES

      Genes, chromosomes & cancer
    94. MURTY VVVS; BOSL GJ; HOULDSWORTH J; MEYERS M; MUKHERJEE AB; REUTER V; CHAGANTI RSK
      ALLELIC LOSS AND SOMATIC DIFFERENTIATION IN HUMAN MALE GERM-CELL TUMORS

      Oncogene
    95. MURTY VVVS; LI RG; HOULDSWORTH J; BRONSON DL; REUTER VE; BOSL GJ; CHAGANTI RSK
      FREQUENT ALLELIC DELETIONS AND LOSS OF EXPRESSION CHARACTERIZE THE DCC GENE IN MALE GERM-CELL TUMORS

      Oncogene
    96. DALLAFAVERA R; YE BH; LOCOCO F; GAIDANO G; LISTA F; KNOWLES DM; LOUIE DC; OFFIT K; CHAGANTI RSK
      IDENTIFICATION OF GENETIC LESIONS ASSOCIATED WITH DIFFUSE LARGE-CELL LYMPHOMA

      Annals of oncology
    97. BOSL GJ; CHAGANTI RSK
      THE USE OF TUMOR-MARKERS IN GERM-CELL MALIGNANCIES

      Hematology/oncology clinics of North America
    98. MATHEW S; MORRISON ME; MURTY VVVS; HOUGHTON AN; CHAGANTI RSK
      ASSIGNMENT OF THE DPP4 GENE ENCODING ADENOSINE-DEAMINASE BINDING-PROTEIN (CD26 DIPEPTIDYLPEPTIDASE-IV) TO 2Q23

      Genomics
    99. MATHEW S; MURTY VVVS; CHEIFETZ S; GEORGE D; MASSAGUE J; CHAGANTI RSK
      TRANSFORMING GROWTH-FACTOR RECEPTOR GENE TGFBR2 MAPS TO HUMAN-CHROMOSOME BAND 3P22

      Genomics
    100. MURTY VVVS; BOSL G; LEBLANCSTRACESKI J; KUCHERLAPATI R; CHAGANTI RSK
      MOLECULAR MAPPING OF 12Q22 DELETIONS IN MALE GERM-CELL TUMORS

      Cytogenetics and cell genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 23:17:16